EPHX2 overexpression deters the advancement of clear cell renal cell carcinoma via lipid metabolism reprogramming
{{output}}
Background: Clear cell renal cell carcinoma (ccRCC) is a prevalent and highly aggressive subtype of renal cancer. EPHX2, a metabolic regulator with tumor-suppressive properties, not only influences cell cycle dynamics but also in... ...
